Group items tagged

American pharmaceutical giant Pfizer has received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) for its medication Etrasimod, marketed as Velsipity, used to treat people with moderately to severely active ulcerative colitis. Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD) that causes inflammation and ulcers (sores) in the lining of the large intestine (colon) and rectum. The approved recommended dose for Velsipity is one 2 mg tablet to be taken once daily. For the first three days, it is advised to take the medication with food, and subsequently, it can be taken daily either with or without food. According to the regulator, the approval of the medication is based on evidence from two clinical studies, which showed that 26 per cent of patients taking etrasimod achieved clinical remission after 12 weeks of treatment compared with 11 per cent of those receiving placebo. The studies included more than 740 patients aged 16 years and over for whom standard treatment or other treatments did not work well enough or could not be used.

Kamila Hawthorne, the chair of the Royal College of General Practitioners (RCGP) Council, was honoured with the GG2 Woman of the Year Award at the annual GG2 Leadership and Diversity Awards, held at the Park Plaza Hotel on Tuesday, 5 March. Hawthorne has been a practitioner and a mentor to young GPs for almost 35 years, and has led pioneering research projects focusing on health inequalities, diabetes and heart disease. She has been recognised twice as GP of the Year for her work with minority ethnic communities. Professor Kiran Patel, Group Chief Medical Officer at University Hospitals Birmingham NHS Foundation Trust, was named the GG2 Man of the Year Award. Apart from being a sought-after cardiologist and consultant, Patel also possesses a wealth of experience in managerial roles. He has done a lot of work in addressing health inequalities, and notably, in 2020, he prescribed the very first COVID-19 vaccine.

More than 300 fully-funded training places will be open to pharmacists and pharmacy technicians working in adult critical care units in England this year. NHS England has awarded a contract to the UK Clinical Pharmacy Association (UKCPA) to deliver 200 funded continuing professional development places for pharmacists and pharmacy technicians from April 2024. Another school of pharmacy, the name of which has not been announced yet, will deliver 100 funded places on a pharmacist adult critical care pathway. There are already 15 funded places on an adult critical care training pathway for pharmacy technicians provided by the University of Bradford. Reacting to evidence indicating workforce concerns in critical care, NHS England invited bids from training providers for delivering the training in November 2023.

Reacting to recommendations from a UK-first independent review, the Department of Health and Social Care (DHSC) has outlined action to tackle potential bias in the design and use of medical devices. Professor Dame Margaret Whitehead, professor of public health at the University of Liverpool, was appointed to lead the review, which focused on three areas - optical devices such as pulse oximeters, AI-enabled devices, and polygenic risk scores (PRS) in genomics. The DHSC commissioned the medical devices review after concerns were raised that pulse oximeters - widely used during the COVID-19 pandemic to monitor blood oxygen levels - were not as accurate for patients with darker skin tones. There were worries that this could cause delays in treatment if dangerously low oxygen levels in such patients were missed. However, no evidence was found from NHS studies indicating that this differing performance had an impact on patient care. Accepting the report's conclusions, the DHSC has committed to several actions, such as ensuring the safe use of pulse oximeter devices across a range of skin tones within the NHS and eliminating racial bias from data sets employed in clinical studies.

The UK based Pharma giant Futura Medical Plc's lead product, Eroxon, a topical Stim-gel is now available on NHS prescription in England and Wales for the treatment of Erectile Dysfunction (ED). The Muti-Drug Resistant (MDR) approved alternative to PDE5i, Eroxon is available as an over-the counter off shelf at retailers like Boots and Superdrug; and is available on NHS prescription in England and Wales as a CE-marked medical device. Erectile dysfunction (ED), also known as impotence, is the inability to get and maintain an erection, typically concerning men over the age of 40 due to both, psychological and physical causes such as anxiety, depression, diabetes, and obesity. According to UK Conformity Assessed (UKCA), the approval of the medication is based on evidence from 2 Phase three clinical studies, which showed that 60 per cent of patients taking Eroxon achieved Minimal Clinically Important Differences (MCID) at 12 weeks.

The Professional Pharmacists Association (PDA) has demanded efforts to secure greater support and recognition for community pharmacists from governmental bodies. In its written evidence provided to the Health and Social Care select committee's pharmacy inquiry, the PDA raised concerns about the well-being of pharmacists, specifically for those who belong to minority ethnic groups and race and are subjected to bullying, harassment, and ill-treatment. The association highlighted issues in the workplace that impact pharmacists' health and well-being, including chronic understaffing, sub-standard working environments, an absence of protected training time, and experiences of racism, violence, and abuse. Parallel to the PDA's advocacy, the Royal Pharmaceutical Society (RPS) is intensifying calls for prioritising workforce wellbeing within the pharmacy domain. Stressing the pivotal role of workforce retention in addressing current challenges, RPS emphasises the need for robust support mechanisms and equitable access to mental health services.

The Department of Health and Social Care (DHSC) and NHS England last month issued a "safety critical" national patient safety alert, warning about the UK-wide shortage of a life-saving drug used to treat patients with chronic breathing issues. NHS trusts, health authorities, ambulance services, GP practices, private healthcare providers, and community pharmacy contractors were informed that salbutamol 2.5mg and 5mg nebuliser liquid unit dose vials are in short supply, with the latter likely to remain "out of stock" until mid-April 2024. As per the alert, the shortage of the drug resulted from a combination of manufacturing issues, leading to heightened demand for alternative suppliers. It was mentioned that while terbutaline, salbutamol with ipratropium, and ipratropium nebuliser liquids remained available, they could't meet the increased demand.

The Medicines and Healthcare products Regulatory Agency (MHRA) has advised the public to exercise caution when buying anti-choking devices online, ensuring these products are purchased from reputable sellers. As estimated by the regulator, more than 10,000 counterfeit or unbranded anti-choking devices have been purchased by the public within the last two years through listings on online marketplaces such as Amazon and eBay, as well as drop-shipping websites. People are cautioned that the use of such products poses a substantial risk of failure in clearing blockages and could exacerbate the situation by pushing obstructions further down into the airway passage. Dr Alison Cave, MHRA Chief Safety Officer, said: "Buying anti-choking devices that do not have a valid UKCA or CE mark increases the risk of receiving a product which does not include appropriate instructions and is either fake or does not meet the UK's regulatory requirements. "These products do not meet our strict quality standards and may put your health and safety at significant risk by failing to resolve or even worsening choking incidents."

As the Easter holiday draws near, pharmacies across Hampshire and the Isle of Wight are readying themselves to provide essential healthcare services to residents. Operational throughout Good Friday (March 29), Easter Sunday (March 31), and Easter Monday (April 1), these pharmacies stand poised to offer vital support to those in need. NHS England has raised awareness by releasing a comprehensive list of pharmacies scheduled to operate during the holiday period. Hampshire residents, including those in Southampton and Portsmouth, can access detailed information about open pharmacies on the NHS England website, along with separate listings for the Isle of Wight. However, it's important to note that opening times may vary, prompting individuals to confirm details before visiting, as schedules are subject to change. Beyond merely dispensing prescriptions, pharmacies are equipped to provide expert advice on minor illnesses and administer treatments for common conditions. This includes addressing issues such as shingles, sore throats, infected insect bites, earaches, sinusitis, impetigo, and uncomplicated urinary tract infections (UTI) under the Pharmacy First scheme.

The States of Guernsey have urged Islanders to plan ahead for their medication needs ahead of the upcoming Easter weekend. With a reduced number of pharmacies expected to be open during the holiday, residents are being asked to arrange for their repeat prescriptions well in advance. Alternatively, the government body announced that residents can opt to wait until after the Easter period if they already have an ample supply of medication at home. This proactive measure aims to provide support to pharmacies and their staff, particularly during a period where demand for healthcare services may be heightened.

Labour's Paulette Hamilton has raised concerns regarding the increasing reliance on pharmacy technicians in clinical practice due to staffing shortages within pharmacies. At the recent Pharmacy Inquiry session, Hamilton highlighted the mounting pressure on technicians to take on more responsibilities beyond their qualifications, attributing it to the launch of Pharmacy First in January. With almost 50,000 Pharmacy First consultations conducted in the first month alone as per a report by the Company Chemists' Association, Hamilton expressed apprehension about technicians being classified under the broad term of "pharmacy professionals," blurring the distinction between their roles and those of clinical pharmacists. She further drew parallels between this situation and the scrutiny faced by physician associates (PAs) in GP practices following a patient's death due to misdiagnosis and cautioned against technicians performing tasks beyond their expertise and urged policymakers to prevent similar incidents in pharmacy settings. Health Minister Dame Andrea Leadsom responded by defending the current approach, denying any "blurring of the edges" and emphasizing patient safety as the top priority.

With the upcoming general election on the horizon, Proprietary Association of Greater Britain (PAGB) is leading the charge to integrate self-care into the core of all political party manifestos. The aim is to ease strains on the NHS and forge a sustainable healthcare system for the future. In a significant move, PAGB unveiled a comprehensive general election toolkit on Wednesday, laying out a compelling argument for the prioritisation of self-care among stakeholders. The toolkit underscores the importance of public interest, potential NHS cost savings, and the economic advantages of the over-the-counter (OTC) sector. Aimed at unlocking the full potential of self-care and nurturing an enabling environment for its implementation, PAGB's toolkit advocates for greater integration of pharmacy services into primary care.

Navigating the complex world of medical insurance can often feel overwhelming, with a myriad of plans, coverage options, and terminologies to understand. However, being well-informed about medical insurance is crucial to making educated decisions that ensure you and your loved ones are adequately protected in times of health emergencies. This blog aims to demystify some of the essential aspects of medical insurance, providing you with 6 crucial pieces of information that everyone should know. Whether you're purchasing your first policy or looking to better understand your current plan, this guide is designed to empower you with the knowledge needed to make informed choices about your healthcare coverage. Expat Options For expatriates living and working away from their home countries, having reliable medical insurance is not just important-it's essential. Navigating healthcare systems in a foreign country can be daunting, and without proper coverage, the financial implications of medical emergencies can be severe. For example, in Dubai medical insurance for your wife's dependents is mandatory, and in the United States, medical bills can easily rack up into the thousands for even minor treatments. Therefore, expats should research their options carefully and ensure that they have comprehensive coverage that meets their specific needs.

Extending its support for the Prescription Charges Coalition (PCC), the Pharmacists' Defence Association (PDA) is asking pharmacists in England to share their experiences of patients denying prescriptions due to financial issues. PDA members who have practiced in the country within the last 12 months are asked to complete the Prescription Charges Coalition survey by Sunday 28 January. The PCC is an alliance of more than 50 organisations campaigning to abolish unfair prescription charges for people with long-term conditions in England. All members of the coalition, including PDA and Royal Pharmaceutical Society (RPS), understand that if patients do not receive their prescribed medicines due to the cost, their health may deteriorate, and this can increase costs for the National Health Service (NHS).

PHOENIX UK has appointed Harry McQuillan, former CEO of Community Pharmacy Scotland, as Chairman of Numark, a community pharmacy membership organisation. It has over 3750 members ranging from single store pharmacies to large chains, spread across the 'Four Nations'. The organisation provides its members with the professional and commercial support they need to deliver exceptional care to local communities. As Numark Chairman, McQuillan will be front and central of representing the interests of the members, and will help ensure policy makers across the UK understand fully "the potential of community pharmacy." Steve Anderson, Group Managing Director, PHOENIX UK, commented: "Harry brings to our Numark partnership an outstanding wealth of experience and understanding of how community pharmacy can work successfully with government officials and politicians.

The UK Health Security Agency's (UKHSA) Chief Executive, Professor Dame Jenny Harries has expressed concern that measles outbreak could spread to other towns and cities unless urgent action is taken to increase Measles, Mumps and Rubella (MMR) vaccination uptake in areas at greatest risk. The virus can spread very easily among those who are unvaccinated, especially in nurseries and schools, she said on Friday (19 January) during a visit to irmingham to review the ongoing work to contain the spread of the disease. A rapid rise in cases has been seen in the West Midlands since 1 October 2023, with 216 confirmed cases and 103 probable cases recorded till 18 January. The majority of the cases (around 80 per cent) were reported from Birmingham, with about 10 per cent in Coventry, mostly affecting children aged under 10 years. Dame Jenny is calling on all local areas to increase MMR vaccine uptake rates in communities across the country.

The NHS England is rapidly expanding the targeted lung health check programme (TLHC) across England to detect lung cancers at an early stage. Launched in 2019, it is a national scheme that identifies people aged 55-74 at increased risk of lung cancer to invite them for a lung health check and chest CT scan, if appropriate. Since then, it has heled detect over 3,000 lung cancers, mostly at an early stage when the condition is more treatable, Dr Jason Page, Clinical Director of South Yorkshire and Bassetlaw targeted lung health checks, revealed in a blog on the NHS website. The decision to initiate the programme follows a study that showed CT screening reduced lung cancer mortality by 26 per cent in men and between 39 per cent and 61 per cent in women.

The King's condition is "benign" and he will be treated in the hospital next week for a "corrective procedure", Buckingham Palace said a statement released on Wednesday. "In common with thousands of men each year, the King has sought treatment for an enlarged prostate," the Palace said. Because of the upcoming surgery, Charles had to postpone all meetings and events planned for this week. The Palace informed that the King's public engagements will be "postponed for a short period of recuperation." Charles, 75, wanted to share the details of his diagnosis to encourage more men who may be experiencing symptoms to get their conditions checked.

Recognising her remarkable contribution in the profession of pharmacy, Christine Gilmour, the Director of Pharmacy at NHS Lanarkshire, has been designated as a Fellow of the Royal Pharmaceutical Society (RPS). Christine, who joined NHS Lanarkshire as trust chief pharmacist for University Hospital Hairmyres and Stonehouse in 1994. She has been in her current role as Director of Pharmacy for 17 years now. Considered to be one of the highest accolades in the domain of pharmacy, this fellowship recognises the distinction of an RPS member in the pharmacy career. NHS Lanarkshire executive medical director, Dr Chris Deighan commented: "We are extremely proud of Christine. This is a fantastic achievement and recognises all the hard work, dedication and expertise Christine has displayed across her career."